N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole

C113H114N28O — CID 157070281

IUPACN,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole
SMILESCC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1.CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1.O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1)c1ccccc1.c1cc(N2CCCCC2)c2nc(-c3n[nH]c4ccc(-c5cncc(CN6CCCC6)c5)cc34)[nH]c2c1
InChIInChI=1S/C31H27N7O.C29H31N7.C27H29N7.C26H27N7/c39-31(20-8-3-1-4-9-20)33-23-16-22(18-32-19-23)21-12-13-25-24(17-21)28(37-36-25)30-34-26-10-7-11-27(29(26)35-30)38-14-5-2-6-15-38;1-2-13-36(14-3-1)26-8-6-7-25-28(26)32-29(31-25)27-23-16-21(9-10-24(23)33-34-27)22-15-20(17-30-18-22)19-35-11-4-5-12-35;1-17(2)29-20-13-19(15-28-16-20)18-9-10-22-21(14-18)25(33-32-22)27-30-23-7-6-8-24(26(23)31-27)34-11-4-3-5-12-34;1-32(2)19-13-18(15-27-16-19)17-9-10-21-20(14-17)24(31-30-21)26-28-22-7-6-8-23(25(22)29-26)33-11-4-3-5-12-33/h1,3-4,7-13,16-19H,2,5-6,14-15H2,(H,33,39)(H,34,35)(H,36,37);6-10,15-18H,1-5,11-14,19H2,(H,31,32)(H,33,34);6-10,13-17,29H,3-5,11-12H2,1-2H3,(H,30,31)(H,32,33);6-10,13-16H,3-5,11-12H2,1-2H3,(H,28,29)(H,30,31)
InChIKeyACIPGUZLYDUGKC-UHFFFAOYSA-N
MW1880.35 g/mol
LogP23.37
Rot. Bonds19

About N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole

N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole (PubChem CID 157070281) has the molecular formula C113H114N28O and a molecular weight of 1880.35 g/mol. Its IUPAC name is N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole.

Molecular Properties

Compound NameN,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole
PubChem CID157070281
Molecular FormulaC113H114N28O
Molecular Weight1880.35 g/mol
Exact Mass1878.97
IUPAC NameN,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole
SMILESCC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1.CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1.O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1)c1ccccc1.c1cc(N2CCCCC2)c2nc(-c3n[nH]c4ccc(-c5cncc(CN6CCCC6)c5)cc34)[nH]c2c1
InChIInChI=1S/C31H27N7O.C29H31N7.C27H29N7.C26H27N7/c39-31(20-8-3-1-4-9-20)33-23-16-22(18-32-19-23)21-12-13-25-24(17-21)28(37-36-25)30-34-26-10-7-11-27(29(26)35-30)38-14-5-2-6-15-38;1-2-13-36(14-3-1)26-8-6-7-25-28(26)32-29(31-25)27-23-16-21(9-10-24(23)33-34-27)22-15-20(17-30-18-22)19-35-11-4-5-12-35;1-17(2)29-20-13-19(15-28-16-20)18-9-10-22-21(14-18)25(33-32-22)27-30-23-7-6-8-24(26(23)31-27)34-11-4-3-5-12-34;1-32(2)19-13-18(15-27-16-19)17-9-10-21-20(14-17)24(31-30-21)26-28-22-7-6-8-23(25(22)29-26)33-11-4-3-5-12-33/h1,3-4,7-13,16-19H,2,5-6,14-15H2,(H,33,39)(H,34,35)(H,36,37);6-10,15-18H,1-5,11-14,19H2,(H,31,32)(H,33,34);6-10,13-17,29H,3-5,11-12H2,1-2H3,(H,30,31)(H,32,33);6-10,13-16H,3-5,11-12H2,1-2H3,(H,28,29)(H,30,31)
InChIKeyACIPGUZLYDUGKC-UHFFFAOYSA-N
XLogP23.37
TPSA341.57 Ų
H-Bond Donors10
H-Bond Acceptors20
Rotatable Bonds19
Heavy Atoms142
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001880.35
LogP ≤ 523.37
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1020

Analyze N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(1S)-2-(dimethylamino)-1-phenylethyl]-3-[6-[(4-pyridin-2-ylphenyl)methylamino]-1H-benzimidazol-2-yl]-1H-indazole-5-carboxamide
CID 136176136
N-[5-[3-(7-pyridin-3-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide
CID 135987311
3-methyl-N-[5-[3-[4-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-5-yl]-3-pyridinyl]butanamide
CID 136509549
N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-2-phenylacetamide
CID 136643028
N-[5-[3-(7-piperidin-1-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide
CID 136643064
N-[5-[3-[4-(4-methylpiperazin-1-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridin-5-yl]-3-pyridinyl]benzamide
CID 137038682
N-[5-[3-(7-pyridin-2-yl-3H-imidazo[4,5-b]pyridin-2-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-3-pyridinyl]benzamide
CID 137041480
N-[5-[3-[4-(4-methylpiperazin-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]benzamide
CID 137114072
5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methylpyridine-3-carboxamide
CID 135532406
N-(3-aminopropyl)-3-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazole-5-carboxamide
CID 172355546
N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]benzamide
CID 136214355
US20240025884, Example 426
CID 170672791

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole?
The IUPAC name of N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole (CID 157070281) is N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole.
What is the SMILES notation for N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole?
The canonical SMILES for N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole is CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1.CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1.O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1)c1ccccc1.c1cc(N2CCCCC2)c2nc(-c3n[nH]c4ccc(-c5cncc(CN6CCCC6)c5)cc34)[nH]c2c1.
What is the InChIKey of N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole?
The InChIKey is ACIPGUZLYDUGKC-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H27N7O.C29H31N7.C27H29N7.C26H27N7/c39-31(20-8-3-1-4-9-20)33-23-16-22(18-32-19-23)21-12-13-25-24(17-21)28(37-36-25)30-34-26-10-7-11-27(29(26)35-30)38-14-5-2-6-15-38;1-2-13-36(14-3-1)26-8-6-7-25-28(26)32-29(31-25)27-23-16-21(9-10-24(23)33-34-27)22-15-20(17-30-18-22)19-35-11-4-5-12-35;1-17(2)29-20-13-19(15-28-16-20)18-9-10-22-21(14-18)25(33-32-22)27-30-23-7-6-8-24(26(23)31-27)34-11-4-3-5-12-34;1-32(2)19-13-18(15-27-16-19)17-9-10-21-20(14-17)24(31-30-21)26-28-22-7-6-8-23(25(22)29-26)33-11-4-3-5-12-33/h1,3-4,7-13,16-19H,2,5-6,14-15H2,(H,33,39)(H,34,35)(H,36,37);6-10,15-18H,1-5,11-14,19H2,(H,31,32)(H,33,34);6-10,13-17,29H,3-5,11-12H2,1-2H3,(H,30,31)(H,32,33);6-10,13-16H,3-5,11-12H2,1-2H3,(H,28,29)(H,30,31).
What are the key properties of N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole?
N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole has a molecular weight of 1880.35 g/mol, XLogP of 23.37, 19 rotatable bonds, 10 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-N-propan-2-ylpyridin-3-amine;N-[5-[3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide;3-(4-piperidin-1-yl-1H-benzimidazol-2-yl)-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole is sourced from PubChem (CID 157070281), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).